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Summary of Main Points 
As was pointed out in the Reports on which this Review is based, to avoid misinterpretation it is 
essential to that the following caveats be entered: 
(i) data in this Review relates to those problem drug users who present for treatment rather 
than all those who have drug problems, or indeed all those who use drugs other than 
alcohol; 
(ii) like most health service data, the information is service dependent and the picture it 
provides of the extent and nature of drug problems will be influenced by drug service 
provision. 
Thus this Review should not be considered as portraying the total picture of drug use, but as 
providing a key element of that picture. The data would be particularly useful when considered in 
conjunction with results from any surveys or other research undertaken. 
MAIN POINTS 
• the number of cases, as distinct from persons, in both the total treatment group and the first 
contact group, who were treated for problem drug misuse in the Greater Dublin Area, 
increased steadily over the five years under review; 
• the rate of treated drug misuse for the total treatment group rose from 4.5 per ‘000 in 1990 
to 7.1 per ‘000 in 1994 and the rate for the first contact group from 1.5 per ‘000 in 1990 to 
3.0 per ‘000 in 1994; 
• the proportion of teenagers in the total treatment group rose from 17 per cent in 1990 to 30 
per cent in 1994 and the proportions for the first contact group were 35 per cent in 1990 
rising to 51 per cent in 1994; 
• while overall the proportions leaving school at or under the school leaving age of 15 
continued to be more than 50 per cent, the trend was downward and participation in 
secondary level increased; 
• the exceptionally high levels of unemployment for both groups were maintained over the 
years; 
• whereas for the total treatment group the proportion whose primary drug of misuse was an 
opiate was always more than 75 per cent, for the first treatment group this proportion was 
only reached in 1994, having been as low as 49 per cent in 1992; 
• the most commonly used primary drug was heroin and there was an increasing proportion 
of those citing heroin in the total treatment group - the increase was even more pronounced 
for the first treatment group; 
• there appeared to be a decrease in the proportion of those injecting their primary drug in 
favour of smoking in both groups; 
 
ix 
• the proportion who had ever injected had decreased steadily for the total treatment group, 
but this was not the case for the first treatment group where the trend seemed to be upward 
since 1992; 
• of the group of those who had ever injected, for the total treatment clients around 70 per 
cent were currently injecting in any given year but for the first contact clients the 
proportion was at its highest in 1993 at 77 per cent; 
• there were some notable differences between males and females over all the years, firstly, 
the proportion of males was always at least three times that of females; secondly, in both 
groups males were proportionately more likely than females to live with their family of 
origin in any given year, in fact there was an upward trend for males but no discernible 
trend for females and finally, in both groups, while no trend emerged, females were always 
proportionately far more likely than males to be living with a drug-using partner. 
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CHAPTER 1 
Introduction 
In assembling this five-year review, based on data returned to the Drug Section of the 
Health Research Board by the participating treatments centres, the author presents the main 
findings and observes any trends which have emerged over the five years 1990-1994 in 
treated drug misuse in the Greater Dublin Area. From the beginning of 1995 onwards the 
reporting system has been extended to cover the country but, as is recognised, up to the 
present most of the drug misuse activity in Ireland has taken place in Dublin. 
Because this is a five-year synthesis of the returns from the Drug Treatment Reporting 
System, in this introductory chapter the review reiterates some of the information given in 
the individual annual reports on the background and the history of the setting up of the drug 
treatment reporting system within the framework of the indicators of drug misuse utilised 
by the Pompidou Group of the Council of Europe. The review also restates some 
information on the expansion of the involvement of the Drug Section of the Health 
Research Board as the Irish focal point in the European Union’s Monitoring Centre for 
Drugs and Drug Addiction. This chapter then sets out the definitions used and 
methodologies employed in the collection and analysis of the data from the drug treatment 
centres and finally notes the content of the following chapters. 
Turning now to the background and history of the setting up of the reporting system, the 
collection of treatment data has its origin in the epidemiology work of the Pompidou Group, 
Council of Europe. A full description of the background to the setting up of this Pompidou 
Group and the collection of treatment data is given in the first report on treated drug misuse 
in the greater Dublin area (O’Hare and O’Brien, 1992). As that description states, the aim of 
the group was defined as an examination, from a multi-disciplinary perspective, of the 
problems of drug abuse and illicit trafficking. The current work within the epidemiology 
sub-group is embodied in the decision made at the 1981 Conference which was to set up 
structures for: 
the development of administrative monitoring systems for the assessment of public 
health and social problems related to drug abuse. 
There were both methodological and substantive objectives set out. As the coordinator of 
the Multi-city Study since its inception in 1983 (Hartnoll, 1995) points out it is not easy to 
obtain valid information on phenomena that are often illegal, stigmatised and hidden. The 
methodological objective emphasised the improvement of the quality usefulness and 
comparability of indicators of drug misuse and the substantive objective was to monitor and 
interpret trends in drug misuse across a network of major European cities. These monitoring 
systems are now in place in 13 European cities including Dublin. They are based on 
information from a range of indicators of drug activity such as, first treatment demand; 
seizures of illicit drugs; drug-related AIDS cases; hospital admissions; viral hepatitis; drug-
related deaths; price/purity of illicit drugs; survey data; persons charged for drug offences 
and imprisonments. However, some indicators are better developed than others in the sense 
that definitive protocols have been put in place by the Pompidou Group. The treatment 
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demand indicator is the best developed and a definitive protocol has been agreed in the 
Pompidou Group. This is the particular indicator on which the data for this Review are 
based. 
It is important to note here, of course, that the reason for the inclusion of a number of 
indicators is that information from one indicator is never sufficient to demonstrate fully 
trends in drug misuse. Analysis of drug misuse must include data from as many indicators 
as possible and supplement this source by information on the legal and socio-cultural 
context of drug taking. 
For the collection of the first treatment data a city approach was adopted by the Pompidou 
Group because the necessary pilot and developmental work at that level could be more 
easily carried out and it would also be easier to take account of the various factors needed 
to interpret the data. As Hartnoll has noted, this was not intended to replace national data 
but rather to complement the somewhat general national picture with the more in-depth 
insight that can be achieved at local level. ‘A further advantage of this approach’ says 
Hartnoll (1995, p.1)’is that it is often in the large cities that new trends are first observed’. 
In Ireland it had been noted that the main problem relating to drug misuse was confined to 
the Greater Dublin Area. Therefore, since 1990, reports have been prepared for that area - 
both statutory and voluntary agencies providing information on an on-going basis. 
The work of the Pompidou Group has been continually guided by directives from 
ministerial conferences and monitored by the permanent correspondents. These latter are 
usually senior civil servants, appointed by each of the participating member states to ensure 
the implementation of the work programme established by the ministers. The Pompidou 
Group maintains close contacts with other intergovernmental and non-governmental 
organisations concerned with problem drug use. Recent proposals have focused on the 
importance of getting some measure of the ‘hidden’ population of drug users not manifested 
by the indicator approach. Such proposals include the desirability of carrying out a 
household survey of the general population, conducting ethnographic studies and improving 
methods of estimating the total number of drug users. This present review is predominantly 
concerned with treated drug misuse in the Greater Dublin Area. However, it might be of 
interest that some short comments are made on two of the other important indicators 
mentioned above, drug seizures and drug-related AIDS. These are national data as a 
breakdown for Dublin is not available. These data are included in Appendix C. 
Returning to the particular indicator concerned here, treatment demand, data from this 
indicator serve two purposes - the first is indirect evidence of trends of drug misuse, that is, 
treated incidence. This refers to the number of people who receive treatment for the first 
time ever. The second purpose of the treatment demand indicator is as a direct indicator of 
the demand on services covered by the reporting system. The establishment of an ongoing 
reporting system also enables socio-demographic information to be collected on first 
contacts, re-contacts and all contacts entering treatment in a given year with the specified 
centres. 
Since one of the main recommendations of the Government Strategy to Prevent Drug 
Misuse (Ireland, 1991) was that a national drugs misuse database should be set up, from the 
beginning of 1995 this was under way with the involvement of centres outside the Dublin 
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area. Reports from 1995 onwards will be national reports. This key development was also a 
response to the increasing international aspect of the drug phenomenon, and together with a 
more integrated Europe means that collaboration between countries concerning the 
collection of useful and comparable information is of growing relevance. Up to now there 
had been no institutionalised monitoring of drugs and drug misuse within the European 
Union itself. As stated earlier the Pompidou Group of the Council of Europe was the 
reference point outside of Ireland. Now the European Monitoring Centre on Drugs and 
Drug Addiction has been set up to cover the countries of the European Union and each 
country has a member on the Management Committee. As previously mentioned, the Drug 
Section of the Health Research Board has been designated as the Irish focal point of this 
new European Observatory sited at Lisbon. 
The emphasis in the Pompidou Group is on the development of indicators and 
methodologies to assess the level of drug misuse within countries and the Council of 
Europe as a whole, while the emphasis in the Monitoring Centre is on joint action against 
drug misuse in Europe. 
METHODOLOGY 
The data analysed in this report are from the reports prepared by O’Hare and O’Brien for the 
years 1990 and 1991 (published 1992 and 1993), from reports prepared by O’Higgins and 
O’Brien for the years 1992, 1993 and 1994 (published 1994 and 1995) with some additional 
cross-tabulations on the data for the five years prepared by O’Brien and Duff. Data for each 
of their clients are entered by the treatment centres on an individual questionnaire. The 
questionnaire was first formulated following pilot work by the Council of Europe, published 
in 1989 and a copy is included in Appendix D. These returns are then sent to and analysed at 
the Health Research Board. All information received is anonymous as no names are entered 
on the the questionnaires. 
Some consideration of the reliability, representativeness and comparability of the data must be 
included under methodology. Where reliability is concerned, the data for the reports, on which 
this review is based, were collected by the staff of the treatment centres. In all cases the data 
were obtained in face-to-face clinical settings. Obviously a full evaluation of the reliability of 
the data was not possible for the reports as it would have involved checking these data against 
other sources, independent of the clinical interviews. It will be noted that there was an amount 
of information missing on certain variables, for instance, level of education and in respect of 
sharing of injecting equipment. A firm definition of the latter variable is problematic as is 
noted in the definitions following. Given these reservations, it is reasonable to assume that the 
data which were provided are sufficiently reliable to give a comprehensive account of treated 
drug misuse. As regards representativeness, the data were supplied by the treatment centres 
noted in Appendix F and cover the main centres, both statutory and voluntary, and most of the 
smaller centres. The level of representativeness would therefore be almost total up to 1994 
when one of the larger voluntary centres was unable to continue to provide data. Turning to 
comparability, the coordinator of the multi-city study extracts the core items from the data 
supplied by the cities involved in the study and bases his report on these items (see: Hartnoll, 
1995). The Dublin reports have always been included in the coordinator’s synthesis. 
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DEFINITIONS USED IN THIS REVIEW 
DRUG MISUSE 
The definition of drug misuse employed in this review is: 
The taking of a legal and/or illegal drug or drugs (excluding alcohol, other 
than as secondary drug of misuse, and tobacco) which harm the physical, 
mental or social well-being of the individual, the group or society. 
DRUG TREATMENT 
The definition of drug treatment is: 
Any activity which is targeted directly at people who have problems with their 
drug use and which aims to ameliorate the psychological, medical or social 
state of individuals who seek help for their drug problems. This activity will 
often take place at specialised facilities for drug users, but may also take 
place in general services offering medical/psychological help to people with 
drug problems. 
Various therapies are used in the treatment of clients at the centres. These range from 
medical treatments, (such as detoxification, methadone programmes or drug-free 
programmes) to non-medical therapies which can include addiction counselling, group 
therapy and psychotherapy. Therapies are generally provided by professionally qualified 
personnel but some centres may deem certain persons, who are not professionally qualified, 
as suitable to undertake some of these therapies. Apart from the therapeutic centres, drug 
treatment may be provided in hospitals, therapeutic communities, residential centres, out-
patient clinics, street agencies, general practices and, of course, in the prisons. Under the 
definition of treatment used in this report, information given over the telephone or 
information solely concerned with queries about social welfare entitlements is not included 
as treatment. 
TOTAL TREATMENT 
The operational definition used is the number of cases who received treatment, as defined 
above, from any of the drug treatment centres listed in Appendix F. 
FIRST TREATMENT 
The definition used for this group is persons who contact and receive treatment for the first 
time from any of the treatment centres. 
CATCHMENT AREA 
The Greater Dublin Area comprises 504 km within Dublin county, which incorporates 
Dublin County Borough, its north suburbs (part of Fingal) and its south suburbs (part of 
Belgard) together with Dun Laoghaire County Borough with its suburbs. The population 
base for the 1990 and 1991 Reports was 920,956, the figure taken from the 1986 Census of 
Population. For the 1992, 1993 and 1994 Reports the population figure was taken from the 
1991 Census of Population and was 915,516. Some breakdowns of these figures are 
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included in Appendices G and F. No details of populations by individual years were 
available. 
PRIMARY DRUG 
The primary drug is defined as the drug which, at the time of the current treatment contact, 
the client alleged was causing most problems and for which he or she had sought treatment. 
FREQUENCY OF USE 
This term refers to the number of times a person had used his or her primary drug 
within the 30 days prior to treatment. 
SHARING 
As noted in all the Reports, ‘sharing’ is a difficult concept to define since its practice is 
understood as quite different by different people. Sharing injecting equipment with a partner 
is often not regarded as ‘sharing’. Therefore it will be difficult to assess accurately the level of 
sharing of equipment. The treatment centres must take their clients’ accounts of their practices 
and the data here are based on the information the treatment centres have obtained from their 
clients. 
DRUG FREE 
The term is used for those people who: 
• were recorded as not having used drugs in the previous month, although in receipt of 
methadone from the methadone maintenance programme; 
• were referred for treatment from prison where they had not been using drugs, or by a 
probation officer and had stopped drug use in the remand period or were referred by 
Narcotics Anonymous; 
• sought counselling when they had stopped using drugs, to avoid relapse. 
OUTLINE OF THE REVIEW 
The structure of the rest of this review is as follows: the first part of Chapter 2 deals with the 
frequency data and identifies (a) socio-demographic characteristics; (b) history of drug misuse 
and (c) injecting and needle-sharing practices of all clients in treatment during the five years 
under review and comments on any trends emerging from these data over the years. The 
second part examines some of the cross-tabulations where indications of trends in increases or 
decreases occur. 
Chapter 3 looks at the frequency data again but this time isolating first treatment clients 
and in the first part identifying some of their (a) socio-demographic characteristics; (b) the 
history of their drug misuse and (c) their injecting and needle-sharing practices in each 
year and discussing any visible trends in either socio-demographic characteristics or drug 
misuse behaviour. The second part of this chapter examines the relevant cross-tabulations 
for the first treatment group. In Chapter 4 an effort is made to give estimations of the exact  
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numbers involved in treatment and the rates per ‘000 of the population aged 15 to 39 years 
old have been calculated. 
Following this there is the final chapter which gives more detail on the trends and discusses 
the possible implications to be drawn from the findings. Given the differences in the 
populations under study it was not possible in this review to make very useful comparisons 
with research findings, The population studied in this report is made up of those being treated 
for drug misuse and since populations studied in other research are chosen from different 
groups the results are thus not directly comparable. Some reference is made to other research 
where relevant research is available. 
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CHAPTER 5 
Discussion and Conclusions 
This final chapter of the review of the trends in the treated drug misuse first comments on 
those trends, relying heavily for likely inferences on the work done by Hartnoll (1995) of the 
Pompidou Group and some other appropriate studies undertaken. The reason for the heavy 
reliance on Hartnoll’s work is that the questions on the form used for the collection of the data 
are dictated by the definitive protocol for the treatment demand indicator of the Pompidou 
Group. The chapter then discusses some of the trends and related matters and concludes with 
a brief look at some issues for the future. 
As has been shown in a number of areas, such as unemployment levels, no particular trends 
were visible over the years. However, they will be included in the comments here because of 
their general importance and possible relevance to the overall picture of treated drug 
misusers. 
AGE AND SEX 
Taking overall age first, all the age categories, mean, median and mode showed a decrease 
over the years for both prevalence and first treatment groups. For both males and females in 
the total treatment group the mean age had dropped over the five years to its lowest at 23.8 
years in 1994. Males’ average age was always slightly younger than that of females. The 
lowering of the mean age for both sexes was also the case for the first treatment group and 
here the range was from 22.8 years in 1990 to 20.6 years in 1994. The finding of a strong age 
effect is similar to that found in the Council of Europe city study. Hartnoll (1995, p.vi) notes 
the age effect increasing through adolescence and young adulthood and subsequently 
declining. 
With regard to any differences between the sexes in the age at which clients come for 
treatment, this is best demonstrated by information on the first treatment group. Up to 1994 
higher proportions of women were likely to come for treatment as teenagers than were men. 
In fact in 1992 and 1993 over half of the women coming for treatment for the first time were 
aged under 20 years old in comparison with around 40 per cent of the men. This changed in 
1994 when over half of the men and 45 per cent of the women were teenagers. From 1992 
onwards, males became increasingly more likely to have first used their primary drug as 
teenagers - the trend was from 64 per cent in 1990 to 81 per cent in 1994. For females, there 
was no particular trend and the proportion was always approaching 70 per cent. For the 
overall data this would seem to contradict the belief of many drug workers before 1992 that 
when women presented for treatment it tended to be later than the age at which men present. 
(Woods, 1992). 
When male/female ratios were examined, for the total treatment group the ratio in 1990 was 
three to one and in 1994 it was four to one. While the proportion of women decreased relative 
to men, the actual number of women, while reaching its highest in 1993, was fairly similar in 
the other years. While obviously there was a rise in the number of males, the rise was not as 
dramatic as for the first treatment group. As with the prevalence group, in the first treatment 
  61 
group, the proportion of males far exceeds the proportion of females. At the lowest point it 
was three to one in 1990 rising to five to one in 1994. Although the proportion of females has 
decreased, the numbers have increased since 1991. This holds for both total and first 
treatment groups. There was a dramatic rise in the number of males in the first treatment 
group over the years. The number increased from the lowest number in 1991 of 380 to 
approaching 1,000 in 1994. These findings are in line with those found in other European 
cities. (See :Hartnoll, 1995, p.vi). 
Some other gender differences emerged from this review. As was noted in Treated Drug 
Misuse, 1990, a publication of the United Nations was devoted specifically to the issue of 
women and drug abuse (United Nations, 1987). That document records that epidemiological 
studies have shown consistent differences in drug use by men and women including higher 
levels of personal distress such as, depression and anxiety and lower levels of self-esteem 
experienced by women. Studies also mentioned in the 1990 report - this time from the UK -
such as Waterson and Ettore (1989) identified problems which might prevent women 
presenting for treatment. These problems could be fear associated with help seeking, of 
embarrassment, of shame and, most important of all as pointed out by Woods (1992), the fear 
of compounding the ‘unfit mother’ notion leading to the fear of losing their children. 
For duration of use before treatment in the case of both men and women ‘the duration of use 
had shortened before treatment commenced. 
Additional differences between the sexes which should be highlighted refer to men being 
much more likely to be living with their family of origin than women but, more importantly, 
proportionately more women than men were living with a drug misusing partner. For both 
groups while there was no particular trend up or down here, the proportionate differences 
between men and women were much more pronounced. The consistent overall finding for the 
first treatment group was that proportionately four times more women than men were living 
with a drug-misusing partner and in the total treatment group the proportion was likely to be 
three times greater for women. Men were proportionately more likely to live with a non-drug-
misusing partner in both groups. Women’s relative lack of power and economic control in 
society generally links their dependence on men with their continuing to live with a drug 
misusing partner. 
Some research, for instance Klee (1993, p.1059), suggests that economic and emotional 
commitment dependence of women on partners leads to underlying anxiety and that injecting 
males prefer non-drug-misusing partners. The finding that proportionately more women were 
living with a drug-misusing partner shows up most clearly when one looks at the table and 
graph referring to currently sharing injecting equipment. Here, while there is no discernible 
trend for either sex, the proportions of women sharing far outweigh the proportions of men 
sharing. In association with that finding Hedrich’s (1990) submission, that a woman’s 
cessation of drug misuse was strongly related to her social relationships and emotional 
support from other people, is appropriate. 
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SOCIAL DEPRIVATION – EDUCATION AND EMPLOYMENT 
The main trend with regard to education was the increase in the participation in some level of 
secondary education but the proportions of clients who had left education either at or below 
the school leaving age continued to be a large majority. 
There was a strong association between high prevalence and relative social deprivation in 
Dublin, instanced by the levels of unemployment which were totally out of proportion to the 
levels in the population, and the generally low education levels for those attending treatment 
centres. These findings held for the five years, particularly as regards unemployment. Perhaps 
in regard to high levels of unemployment relative to the unemployment level in the total 
population, one must consider the areas in question, in that some of the areas of social 
deprivation from which the drug misusers come would have unemployment levels of similar 
dimensions to those found among drug misusers (see, for instance, O’Gallagher, 1990). 
Therefore, the population under study here would be from areas of high unemployment and 
be unemployed themselves. However, as Hartnoll (1995, p. 65) points out an association 
between drug use and measures of social class is not simple. The relationships may differ for 
drug use per se and have more serious patterns of addiction. Hartnoll goes on to relate that in 
some cities (e.g.Amsterdam, Barcelona) drug use (largely cannabis) as measured by 
population surveys tends to be higher in middle-class areas or amongst people with higher 
educational level. In Oslo, however, cannabis use is higher amongst young people who do not 
complete school. As regards addiction, there is a strong association in several cities between 
high prevalence and relative social deprivation (e.g. Barcelona, Dublin, Paris, Stockholm). 
Hartnoll contends that this is not true in all cities, for example, heroin addiction is more 
widely spread across social groups in Geneva and possibly London. 
PRIMARY DRUG 
There was a dramatic rise in the proportions citing heroin as their most commonly used 
primary drug - from 39 per cent in 1990 to 56 per cent in 1994 for the total treatment group 
and an even more dramatic rise - from 22 per cent to 59 per cent - for the first treatment 
group. Of all the drugs listed, heroin was the only one where an upward trend could be 
observed. Although media attention has for the most part been concentrated on ecstasy, it is 
likely that heroin will continue to be the primary drug associated with requests for treatment. 
The increases in the misuse of heroin as a most commonly used drug was, of course, reflected 
in the diminishing proportions of other groups of drugs. For instance, the proportion misusing 
MSTs declined from 33 per cent in 1990 to 19 per cent in 1994. For the first treatment group 
this decline was even more dramatic - from 32 per cent in 1990 to 9 per cent in 1994. No 
particular trend was seen in the use of cannabis and the proportion remains in very low double 
figures for the total treatment group but there did appear to be a downward trend in the case 
of the first treatment group, particularly since 1991. 
Regarding the use of other substances, which would include, for instance, volatile inhalants 
and tranquilisers, the numbers involved in treatment were small, so therefore comment on 
likely trends would not be meaningful. 
If age first used primary drug is considered, the majority of those in the total treatment group 
had first used their primary drug when aged under 20 years old. However, the proportion is 
fairly constant over the five years, whereas with the first treatment group, which it will be 
remembered are younger, there was an increasing majority first using their primary drug as 
teenagers. 
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ROUTE OF ADMINISTRATION 
The importance of reducing the health risks associated with injecting are well known. Here 
three sets of data are noted: (i) actual route of administration of primary drug; (ii) where this 
was injecting, the proportion and number who had ever injected and (iii) the proportion and 
number of current injectors. For the total treatment group taking (i) when the trends here in 
the proportion of clients who injected their primary drug are examined, it will be seen that 
there was a slight downward trend in injecting as a route of administration. This was 
counterbalanced by a rise in the proportion of clients who smoked their primary drug. There 
was a gradual fall in (ii) the proportion who had ever injected. The trend in (iii) the proportion 
of those currently injecting, was also downward. When actual numbers were considered the 
number whose route of administration of primary drug was injecting was on the increase, 
although as has been shown, the trend in the proportions was decreasing. As regards (ii) those 
who had ever injected, the numbers here had also increased. When the data on whether or not 
the people were currently injecting was examined, in the total treatment group a fairly stable 
proportion of around 70 per cent were currently injecting since 1992. 
Where the first treatment group was concerned, since 1992 both the proportion and the 
number of those whose route of administration was injecting had risen. There was no 
discernible pattern over the years, proportionally speaking, for those who had ever injected 
but where the numbers were concerned, there was a continual rise from 1991. Whether this 
means that there is an increase in the numbers of those who are injectors coming for treatment 
for the first time or an increase in the overall number of injectors is impossible to say, but it is 
to be hoped that the harm reduction approach is successful in reaching those likely to be in 
danger from their use of injecting as a route of administration of their primary drug. “Some 
patterns of drug use (e.g. injecting) are rare in the general population” says Hartnoll (1995, 
p.3) “but when concentrated in particular groups can have consequences disproportionate to 
their numerical dimensions in terms of costs to the community, health care systems or 
institutions such as the prisons”. 
ISSUES FOR THE FUTURE 
It is not intended in this brief look at issues for the future to try to cover all aspects of what is 
being done and what is likely to occur in the future in this complex area. It will merely be a 
short discussion of some of the more important actions and progress being made at present or 
that will be made in the future. 
Ireland cannot act unilaterally with regard to the drug problem. There are a variety of social 
and economic developments in Europe likely to impinge on drug use and drug markets in the 
coming years. Hartnoll (1995, p.75) would see these as rising unemployment, economic 
recession, demographic changes, new patterns of migration and immigration, changing 
patterns of employment in industry, agricultural and service sectors, developments in urban 
living and leisure activity and the rapid changes in eastern Europe and other parts of the 
world. Several population groups may be particularly vulnerable amidst these changes and 
some of the groups can be found in Ireland. For instance, vulnerable groups would include 
young people growing up in socially and economically disadvantaged communities, young 
people moving from areas of declining agriculture or industry and indeed, broader groups of 
young people 
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It would be accepted that the reasons why people take drugs are multiple and complex and 
that therefore a range of strategies is needed to deal with the problems that may arise from the 
use and misuse of legal and illegal drugs. In his launch of details of the new Government 
demand reduction measures to prevent drug misuse, the Minister for Health announced that 
the Department of Health has been preparing a strategy, in consultation with the Departments 
of Education and Justice and health agencies which will form the basis of the demand 
reduction response (Ireland, 1996). The strategy to be used is based on two key elements: 
reducing the number of people turning to drug misuse in the first instance through 
information, education and prevention programmes and secondly, providing a range of 
treatment options for those addicted to drugs, the ultimate objective of which must be a return 
to a drug free life style, although the Minister accepted that this may not be a realistic goal in 
every instance. 
Many different ways of reducing drug use and the harms associated with it have been tried, 
but prohibition obviously needs the support of other methods, since by itself it manifestly 
does not succeed in eliminating supply and does nothing to control the demand for drugs. 
In tackling the problem of drug misuse one of the actions of the Department of Health and the 
Department of Education is to aim information and harm reduction messages at both primary 
and secondary level pupils. Children have some knowledge of drugs, however incomplete and 
inaccurate, from an early age and, as is evidenced from the data in this review, will start to use 
drugs while still in primary school. Because many young people will try drugs regardless of 
any educational intervention, they need to be provided with harm reduction messages that can 
reduce the risk of their drug use. Of course, the effectiveness of drug education has not yet 
been established and probably some evaluation of the programmes would be useful. On 
education itself, in the UK Clements and Buczkiewicz (1993) and Jack and Clements (1994) 
argue that because young people may be more likely to listen to other young people than they 
are to adults, one way of getting such messages across are ‘peer-led’ approaches, which are 
currently popular in the UK, particularly in informal education but also in schools. These 
cover a range of approaches involving both older children delivering harm reduction 
messages to their younger school-mates and ‘same-age’ peer education involving pupils 
educating their class-mates. The Health Promotion Unit of the Department of Health is at 
present seeking tenders for a multi-media campaign, aimed at prevention, to be introduced 
into schools. 
Ives (1996) recommends that drug education should take place within a broad framework of 
health and social education which embraces discussion about healthy living. However, Ives 
warns that this approach inevitably means entering into difficult territory. Health education is 
a highly charged topic and there is disagreement about what ‘healthy living’ actually means. 
Teacher training, both initial and in-service, is vital he contends. Also in his discussion of 
drug education Ives (1996) sounds a cautionary note, saying that secondary school pupils’ 
knowledge is often considerably greater, and in many cases likely to be gained through 
personal experience of drug use. The young are more likely to have used drugs than older 
people: in this respect they have more knowledge about drugs than many of their teachers. 
Therefore, didactic drug education on its own is unlikely to be effective, although it may be 
necessary to counter some of the misinformation that young people have about drugs with a 
clear account of the facts appropriate to their age and their level of understanding. 
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Among the useful initiatives the Department of Justice is putting into operation is that of 
addressing the drugs problem in prisons. This problem has caused much comment and 
discussion. A decision on the plans for the preparation of the Training Unit at Mountjoy 
Prison to be used as a drug free unit have been taken. Currently the issue of introducing a 
methadone treatment programme for general prisoners is being examined with experts from 
Ireland and the United Kingdom studying the best means for implementing such a 
programme. This action is being taken within the framework of putting in place a more 
effective treatment regime in the prison system at large. The coordination of the work 
between the Gardai, Customs and Naval services is another beneficial initiative which should 
provide invaluable support to action on supply reduction. 
Hartnoll (1995, p.65) remarks that surveys of drug use show higher prevalence rates for 
illegal drugs in urban than in rural areas. However, these differences often diminish or 
disappear for solvents and mixtures of legal drugs (pills, alcohol). Similarly, says Hartnoll, 
addiction is concentrated in the cities but the “magnetic” effect of the illicit market in 
attracting people from outside of the city may give an impression of prevalence levels which 
are higher than those based on addicts who are native residents of the city. If this is true for 
Ireland, then the prevalence rate for Dublin may be exaggerating the true level because of 
those people being treated in Dublin, who may be resident only for the purpose of obtaining 
treatment in Dublin. 
One vital component in policy-makers information and ability to act in responding to the 
problem of drug misuse is the level of reporting of treated drug misuse should be at the 
optimum level. From time to time some voluntary organisations have been unable to return 
data because of lack of resources, both human and technical. This deficiency distorts the 
overall figures and retards efforts of policy makers in assisting these voluntary organisations 
in their work, since evidence of the critical contribution these voluntary organisations make is 
not included in the picture of treated drug misuse presented in the reporting system. 
Finally, the evidence of increasing numbers in treatment leads to the question as to whether 
the increases are artifacts of better reporting and a greater provision of services or is the 
number of drug misusers in the community actually increasing? Without some estimation of 
overall prevalence, the answer to that question must remain in the realms of speculation. It is 
hoped that efforts will be made towards a response to this question of the true number of 
misusers in the population. Methodologies to achieve reliable data on this difficult 
undertaking are being discussed at present in the Pompidou Group at the Council of Europe. 
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